While pharmaceutical supply chains have become increasingly complex, the supply of many essential health products relies on a limited number of producers from a handful of major manufacturing hubs. Over-consolidation of the pharmaceutical market makes supply chains vulnerable to disruptions and impedes access to essential medicines for millions of patients, especially in low- and-middle-income countries.

We work to strengthen regional and local manufacturing capacity of medicines, vaccines, personal protective equipment, medical devices, and other health products to provide more equitable access for patients and communities worldwide.